Latest News

Is HbA1c failing as the standard diabetes test for people in South Asia

The standard diabetes test, HbA1c (glycated haemoglobin), which is commonly used to diagnose and monitor type-2 diabetes (T2D), may not always give accurate results for people in South Asia, especially in India. This is because many people in the region have anaemia, blood disorders like sickle cell disease or thalassaemia, and G6PD deficiency, which can affect HbA1c readings. A recent article published in Lancet Regional Health: Southeast Asia highlighted these concerns. The study suggests that relying only on HbA1c to diagnose or monitor type-2 diabetes may mislead doctors and patients in South Asia. The review was led by Anoop Misra,

India and Pakistan war could have been nuclear, 10 planes were shot down: Trump

New York/Washington, Feb 11 (PTI) US President Donald Trump repeated the claim that he stopped the war between India and Pakistan last year, which he said could have turned nuclear, through tariffs. “I settled eight wars. Of the eight wars, at least six were settled because of tariffs. In other words, I said, ‘if you don’t settle this war, I’m going to charge you tariffs, because I don’t want to see people getting killed,” Trump said in an interview to Fox Business Tuesday. “And they said, ‘Well, what does this have to do?’ I said, ‘you’re going to be charged’.

Rupee lumbers in narrow band, volatility expectations retreat

MUMBAI, Feb 11 (Reuters) – The Indian rupee traded in a tight range on Wednesday, wedged between a broadly weaker dollar and steady corporate hedging appetite, while expectations of volatility in the currency receded after jumping last week. The rupee was at 90.53 per dollar as of 11:15 a.m. IST, slightly firmer than its previous close of 90.5775. The currency has settled into a broad 90-91 trading range after a relief rally last week, sparked by the announcement of the U.S.-India trade deal. While near-tenor implied volatility, a gauge of future expectations, had jumped to a seven-month peak immediately after

Indian shares flat as broad pullback counters post-results rise in Apollo, Eicher

BENGALURU, Feb 11 (Reuters) – Indian equity benchmarks were little changed on Wednesday, as broad-based losses after a recent market rally pressured the earnings-driven surge in hospital chain Apollo Hospitals and Royal Enfield parent Eicher Motors. The Nifty 50 fell 0.04% to 25,925.8, while the BSE Sensex shed 0.09% to 84,197.76, as of 10:16 a.m. IST. Eleven of the 16 major sectors logged losses. The broader small-caps and mid-caps fell about 0.4% each. Heavyweight banks and financials fell 0.2% and 0.1%, respectively, while state-owned lenders lost 1%. The sectors had gained almost 1%-2.8% in the last three sessions. The IT

1 … 414 415 416 417 418 … 1,594